Meridian Bioscience Reports First Quarter Fiscal 2020 Operating Results and Reaffirms 2020 Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ABBV
3. META
4. SPY
5. IBM
6. MU
7. FDX
8. BLZE
9. NKE
10. PRIM

Go back to Meridian Bioscience Reports First Quarter Fiscal 2020 Operating Results and Reaffirms 2020 Guidance

Meridian Bioscience (VIVO) Tops Q1 EPS by 4c, Reaffirms Guidance

February 7, 2020 7:35 AM EST

Meridian Bioscience (NASDAQ: VIVO) reported Q1 EPS of $0.10, $0.04 better than the analyst estimate of $0.06. Revenue for the quarter came in at $47.4 million versus the consensus estimate of $48.7 million.

GUIDANCE:

Meridian Bioscience sees FY2020 EPS of $0.28-$0.34, versus the consensus of... More